Re: 3 in 2 weeks
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: 3 in 2 weeks
Imagine how profitable a BO/merger with PTSC might be. The candidate company effectively receives a 50% price break on the MMP license. That's a good incentive to consider and also a lever if we get into the greenmail business. Just thinking out loud.
Now on with amending my 06' returns.
New Message
Please
login
to post a reply